Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.

Sharma N, Goel M, Bansal S, Agarwal P, Titiyal JS, Upadhyaya AD, Vajpayee RB.

Ophthalmology. 2013 Jun;120(6):1173-8. doi: 10.1016/j.ophtha.2012.11.013. Epub 2013 Feb 15.

PMID:
23415776
2.

Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.

Shah VM, Tandon R, Satpathy G, Nayak N, Chawla B, Agarwal T, Sharma N, Titiyal JS, Vajpayee RB.

Cornea. 2010 Jul;29(7):751-7. doi: 10.1097/ICO.0b013e3181ca2ba3.

PMID:
20489580
3.

Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.

Ophthalmology. 2007 Sep;114(9):1622-9.

PMID:
17822972
4.

Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.

Sharma N, Arora T, Jain V, Agarwal T, Jain R, Jain V, Yadav CP, Titiyal J, Satpathy G.

Cornea. 2016 Jan;35(1):56-61. doi: 10.1097/ICO.0000000000000664.

PMID:
26509763
5.

Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P.

Arch Ophthalmol. 1995 Oct;113(10):1257-65.

PMID:
7575256
6.

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.

Ophthalmology. 1996 Nov;103(11):1854-62; discussion 1862-3.

PMID:
8942881
7.

Moxifloxacin for bacterial keratitis.

Rosenberg J, Eisen L, Kim J.

Ophthalmology. 2008 Jun;115(6):1103; author reply 1103. doi: 10.1016/j.ophtha.2007.11.020. No abstract available.

PMID:
18519075
8.
9.

Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.

Khokhar S, Sindhu N, Mirdha BR.

Infection. 2000 May-Jun;28(3):149-52.

PMID:
10879638
10.

Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.

Gangopadhyay N, Daniell M, Weih L, Taylor HR.

Br J Ophthalmol. 2000 Apr;84(4):378-84.

11.

Monotherapy versus fortified antibiotics for bacterial keratitis.

Rosenberg JB, Gritz DC.

Cornea. 2011 Sep;30(9):1066; author reply 1066-7. doi: 10.1097/ICO.0b013e31820ce2a1. No abstract available.

PMID:
21775886
12.

Fluoroquinolones in corneal ulcers.

Galvis V, Tello A, Guerra AR, Acuña MF, Villarreal D.

Ophthalmology. 2013 Sep;120(9):e61-2. doi: 10.1016/j.ophtha.2013.06.005. No abstract available.

PMID:
24001539
13.

Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group..

Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10.

14.

The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group..

Am J Ophthalmol. 2014 Feb;157(2):327-333.e3. doi: 10.1016/j.ajo.2013.09.025. Epub 2013 Oct 1.

15.

The steroids for corneal ulcers trial: study design and baseline characteristics.

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group..

Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10.

16.

Nocardia keratitis: clinical course and effect of corticosteroids.

Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR.

Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5.

17.

Author reply: To PMID 23415776.

Sharma N, Goel M, Bansal S, Agarwal P, Titiyal J, Upadhyaya A, Vajpayee R.

Ophthalmology. 2013 Sep;120(9):e62. doi: 10.1016/j.ophtha.2013.06.004. No abstract available.

PMID:
24001541
18.

Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840.

19.

Fourth-generation fluoroquinolone-resistant bacterial keratitis.

Jhanji V, Sharma N, Satpathy G, Titiyal J.

J Cataract Refract Surg. 2007 Aug;33(8):1488-9.

PMID:
17662450
20.

Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.

Bashir H, Dave A, Mathur U.

Cornea. 2016 Aug;35(8):e22-3. doi: 10.1097/ICO.0000000000000897. No abstract available.

PMID:
27227400

Supplemental Content

Support Center